Skip to main content

We are currently working on the 2024 Program.
See the previous year's program below:

12th EPP Life Sciences Pricing Forum 2023
Program

What's Next - Pricing in the New Reality

Pre-order the 2024 brochure

PRE-FORUM WORKSHOPS October 17, 2023

12.00 - 13.00

WELCOME LUNCH & REGISTRATIONS

13.00 - 14.00

WORKSHOP 1

Workshop on International Reference Pricing: Best in class operations

An interactive workshop to address the IRP topic from an operational point of view

Current challenges, what works, what does not work; from a process, tool and data point of view.

Pricia Team

14.10 - 15.10

WORKSHOP 2

Marbls Tender Simulation Game: “Tender Nation” – from Planning to Winning


This pricing & tendering training workshop is designed for tendering professionals to help to understand how to improve their tender business by conducting an interactive Simulation Game.
Marbls’ Tender Simulation Game ‘Tender-Nation’ runs multiple scenarios in a competitive environment of several manufacturers with different profiles & capabilities but the same objective of winning the tender business – sustainably over time! The group will be split in teams by company and compete in multiple tender scenarios/waves. No prior knowledge of simulated market environment is needed, and the focus will be on data and analysis for decision-making, while applying your business sense and acumen. It’s an interactive session with facilitation of debriefs per wave and lessons learned.

Marbls Team

15.10 - 15.30

COFFEE BREAK

15.30 - 16.30

WORKSHOP 3

Pricing in the AI Era: What practical use cases are already at play and how to enable them

Learn how pharma and MedTech companies are using  AI and ML to gain competitive advantage on topics like tender management, sales & revenue forecasting, pricing optimization, loss of exclusivity strategy and others…

Reflect with experts on your company trajectory for these topics and what they entail from a change management perspective.

Monitor Deloitte Team

16.40 - 17.40

WORKSHOP 4

Practical Uses of AI in Pricing & Access
An incredible hands-on workshop allowing participants to work through real-world problems at all stages of the lifecycle with AI and machine-learning driven tools, allowing people to massively increase their familiarity with these tools and experience first hand where and how they work well – and where they fall short or fail.

Survey of AI techniques in Pricing & Market Access, reviewing applicability of each technique

Predictive pricing, HTA decision outcomes, ChatGPT-style queries of price & access information stores, etc.

Detailed hands on use of AI tools to tackle practical problems

Eversana Team

Conference Day - 1 October 18, 2023

8.00 - 8.30

WELCOME COFFEE & REGISTRATION 

8.30 - 8.50

Welcome by the President of EPP - Pol Vanaerde - President - EPP

Opening Remarks - Dare to Ask

Session 1:
PRICING STRATEGIES TO COPE WITH NEW TRENDS AND NEW REGULATIONS
8.50 - 9.20

Understanding New Regulations, New Trends and How to Adapt

Alan Crowther - General Manager Global Pricing Access Solution - Eversana

9.20 - 9.50

EU Pharmaceutical Legislative Review: Impact on market access, pricing and reimbursement across countries

Thomas Bols - Head of Government Affairs and Patient Advocacy, EMEA & APAC - PTC Therapeutics

9.50 - 10.20

Pricing as a Lever During Inflationary Times

Gianfranco Parlato - Head of Global Pricing Excellence - Servier Pharmaceuticals

10.20 - 10.40

The Political Perspective on New Pharma Regulations in Europe 

Emma Eatwell - Practice Director - Global Counsel

10.40 - 11.10

COFFEE BREAK - BE BACK IN 30 MINUTES!

11.10 - 11.40

Global Pricing, Net Pricing: What is inflation and why does it occur?

Peter Zimmermann - Senior Director Professional Services - Model N

11.40 - 12.10

State Innovation Waivers: Important lessons from the US Affordable Care Act.

Sebastian Gensior - Founder - Slate Mountains Capital

12.10 - 12.40

The Canadian Pricing & Market Access Model: A new emphasis on innovation?

Neil Palmer - Strategic Advisor - PDCI

12.40 - 13.40

"ASK ME ABOUT" ONE HOUR FOR LUNCH AND NETWORKING OPPORTUNITIES

Session 2:
BUILDING SUSTAINABLE AND EQUITABLE PRICING MODELS
13.40 - 14.10

Equitable Pricing, Differential Pricing and Fair Patient Access

Laurene Redding - Global Head, Value, Access & Pricing - BeiGene

 

14.10 - 14.40

Navigating Patient Access and Equitable Pricing: Addressing Challenges and Exploring Solutions

Michael Hemmann - Capability Lead Pricing, Contracting and Tendering - Boehringer Ingelheim

Gianfranco Parlato - Head of Global Pricing Excellence - Servier Pharmaceuticals

PANEL MODERATED BY: Alejandra Garitonandia - Industry Principal for Life Sciences - Vistex

14.40 - 15.10

Understanding the Impact of Pricing Practices and Regulations on Equity and Equality 

Giovanny Leon - Global Healthcare Executive - Novartis

15.10 - 15.40

COFFEE BREAK - BE BACK IN 30 MINUTES!

15.40 - 15.50

EPP Remarks

15.50 - 16.20

Supporting Sustainable Access Through Equitable Pricing Principles

Benoît Donze - Director, EU Pricing & Reimbursement Lead - Amarin Corporation

Enric Muñoz - Sr. Director, Global Market Access - Global Rx Pricing Head - Galderma

Omar Ali - Former Advisor to NICE, Lecturer - University of Portsmouth

PANEL MODERATED BY: Ian Tidswell - Co-Founder - Ideal Price 

16.20 - 16.50

Algorithms, Artificial Intelligence, and Big Data in Tender Pricing and Forecasting

Praful Mehta - CEO - Vamstar

16.50 - 17.20

Loss of Exclusivity Strategy – Setting up for success

Marc Abels – Partner - Strategy, M&A & Analytics leader - Lifesciences – Monitor Deloitte

17.20

Closing remarks 

Conference Day - 2 October 19, 2023

8.00 - 8.30

WELCOME COFFEE

8.30 - 8.40

Opening Remarks - The Magic Key

Session 3:
PRICING CHALLENGES & OPPORTUNITIES HTA, RWE AND VBHC
8.40 - 9.00

Measuring Market Access Success

Alan Crowther - General Manager Global Pricing Access Solution - Eversana

9.00 - 9.30

Value Based Contracting: How to realize it?

Andrea Mantovani - VP Global Pharma Service - Alira

9.30 - 10.00

Use of Real World Data and Real World Evidence to Getting a Price

Daniel Muscionico - Senior Lecturer - Faculty of Medicine of the University of Geneva, Institute of Global Health

10.00 - 10.30

How to align HTA and health care decision making in Switzerland

Goedele van Haasteren - Swiss Ministry of Health - Bundesamt für Gesundheit

10.30 - 11.00

COFFEE BREAK - BE BACK IN 30 MINUTES!

11.00 - 11.30

Developing the Optimum Price Design for your Innovative Life Sciences Solution

Ian Tidswell - Co-Founder - Ideal Price 

11.30 - 12.00

BREAKOUT 1

   

BREAKOUT 2

From Sci-Fi to Hi-Fi: Embracing the human touch in the digital era

Alejandra Garitonandia - Industry Principal for Life Sciences - Vistex

   

Optimizing Pricing Across the Late Lifecycle

Paw Trebbien - Founder and CEO - Pricia

               
12.00 - 13.00

"THE MAGIC KEY" ONE HOUR FOR LUNCH AND NETWORKING OPPORTUNITIES

Session 4:
INNOVATIVE STRATEGIES AND METHODS
13.00 - 13.30

Gross-to-Net Transparency in Pharma - Driving Transparent Decisions and Profits

Christian Zuberer - Managing Director - Accenture

13.30 - 14.00

Pricing optimization through ‘Gross to Net’: An industry example

Kaushal Kishore - Pricing Transformation Consultant - Merck

14.00 - 14.30

BREAKOUT 3  

   

BREAKOUT 4

Realizing Pricing Value in a Post-Inflationary Environment

Michael Stanisz - Partner - Revenue Management Labs

         

Practical Applications of Generative AI in the domain area of Pricing and Contracting

Ruven Eul - Principal Life Sciences - Marbls

Przemyslaw Kuznicki - Principal CIO - Marbls

                 
14.30 - 15.00

COFFEE BREAK - BE BACK IN 30 MINUTES!

15.00 - 15.30

Can we afford a cure? 

Omar Ali - Former Advisor to NICE, Lecturer - University of Portsmouth

15.30 - 15.50

Tenders and Technology Trends - Watch Out for AI

Abhishek Batla - Director Project Management - Model N

Peter Zimmermann - Senior Director Professional Services - Model N

15.50 - 16.20

The Fast Growth of AI/ML: Key steps to safely employ these new tools and techniques

Li Mowei - Global Pricing Analytic Innovation and North America - Sanofi

Neil Palmer - Strategic Advisor - PDCI

16.20

Closing remarks 

Detected timezone